NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.49
-0.06 (-0.32%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovoCure Market Cap
NovoCure has a market cap or net worth of $2.06 billion as of April 25, 2025. Its market cap has increased by 31.73% in one year.
Market Cap
2.06B
Enterprise Value
1.83B
1-Year Change
31.73%
Ranking
Category
Stock Price
$18.49
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has increased from $1.51B to $2.06B, an increase of 36.47%. That is a compound annual growth rate of 3.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2025 | 2.06B | -36.03% |
Dec 31, 2024 | 3.22B | 102.11% |
Dec 29, 2023 | 1.60B | -79.28% |
Dec 30, 2022 | 7.70B | -1.24% |
Dec 31, 2021 | 7.79B | -55.75% |
Dec 31, 2020 | 17.62B | 111.21% |
Dec 31, 2019 | 8.34B | 167.82% |
Dec 31, 2018 | 3.11B | 72.52% |
Dec 29, 2017 | 1.81B | 164.99% |
Dec 30, 2016 | 681.20M | -63.57% |
Dec 31, 2015 | 1.87B | 23.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 744.81B |
UnitedHealth Group | 389.54B |
Johnson & Johnson | 374.44B |
AbbVie | 313.20B |
Novo Nordisk | 276.62B |
Abbott Laboratories | 225.18B |
AstraZeneca | 213.42B |
Novartis AG | 208.99B |